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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296S78in the apoptotic pathway were overrepresented. Currently, we are vali-
dating the data by RT-qPCR. Our exploration may be a valuable tool for
assessing genes underlying networks predicting susceptibility to OA or
marking the ongoing disease.
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EFFECT OF A 16 WEEKS WEIGHT LOSS PROGRAMME ON CARTILAGE
BIOMARKERS IN OBESE PATIENTS WITH KNEE OSTEOARTHRITIS:
A PROSPECTIVE COHORT STUDY
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Purpose: Knee osteoarthritis (KOA) is a common disease where easily appli-
cable, well-deﬁned and objective tools for monitoring clinical improvement
following treatment are not clearly deﬁned; biomarkers could be such a tool.
Weight loss is a recommended treatment for obese KOA patients, and short-
term assessment of cartilage degradation is important. The aim of this study
was to follow changes in cartilage markers Serum Cartilage Oligomeric Matrix
Protein (S-COMP) and urine C-terminal telopeptide of collagen type II (U-CTX-
II), and bone marker urine C-terminal telopeptide of collagen type I (U-CTX-I),
over 16 weeks intensive weight loss in KOA patients.
Methods: 192 subjects from the outpatient clinic at Department of Rheu-
matology, Frederiksberg Hospital, Denmark were exposed to 16 weeks of
weight loss (the CAROTstudy). Patientswere over 50 years of agewith a body
mass index  30 kg/m2, and conﬁrmed KOA on standing semi-ﬂexed radio-
graphs. S-COMP, U-CTX-II and U-CTX-I were determined by ELISA. To assess
the symptomatic improvement, the change from baseline to 16 weeks in the
average score on four subscales of the Knee Injury and Osteoarthritis
Outcome Score (KOOS) _ pain, symptoms, function, and knee-related quality
of life (KOOS4; range of scores, 0 [worst] to 100[best]). The statistical analysis
was based on a general linear model, applying Analysis of Covariance
(ANCOVA) with a factor for sex, with BMI and age at baseline both applied as
covariates. Toassess thebivariate associationbetweeneachof thebiomarkers
with changes in body weight and KOOS4, Pearson Correlation Coefﬁcients
applied with a P-value 0.05 (two-tailed) indicating statistical signiﬁcance.
Results: 91% (175) of the patients completed the 16weeksweight loss scheme.
Themeanweight loss was 13.4 kg (95%CI: 12.5 to 14.4, P< .0001), mean loss of
fatmass11.2 kg (10.4 to11.9, P<.0001), andmaybeasmall (non-signiﬁcant) loss
in lean body mass (0.7 kg; P¼.089). By self-assessment, the patients showed
a signiﬁcant improvement of 10.0 on KOOS-4 (7.7 to 12.3, P<.0001). Looking at
biomarkers at the group level, S-COMP decreased signiﬁcantly with a mean of
1.1 U/l (0.7 to 1.5, P<.0001), while U-CTX-II increased with a mean of 63 ng/
mmol creatine (25 to 101, P¼.0013), and U-CTX-I increased with a mean of 66
mg/mmol creatine (46 to 86, P<.0001). On the individual participant level,
change in S-COMPwas correlated toweight change,with adecrease in S-COMP
withdecreasedweight (r¼-.16, P¼.03),whileU-CTX-II showednocorrelation to
weight loss (r¼.11, P¼.16). U-CTX-I increasedwithweight loss (r¼.22, P¼.0048).
U-CTX-II showedastrongcorrelation toKOOS-4,withdecreasingU-CTX-IIwith
improvement inKOOS-4 (r¼-.28, P¼.0002),while S-COMPandU-CTX-I did not
correlate to KOOS-4 (P>.097).
Conclusions: A weight loss over 16 weeks in obese knee osteoarthritis
patients causes a reduction in S-COMP concentration directly associated
with themagnitude of weight loss. Changes were also seen in U-CTX-II and
U-CTX-I, but only the latter was correlated to the weight loss magnitude.
This study was supported by The Oak Foundation, The Velux Foundation,
and The Cambridge Weight Plan.
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ASSOCIATIONS OF CTX-II WITH BIOCHEMICAL MARKERS OF BONE
TURNOVER RAISE QUESTIONS ON ITS TISSUE ORIGIN: DATA FROM
CHECK, A COHORT STUDY OF EARLY OSTEOARTHRITIS
W.E. van Spil, J.W. Bijlsma, S.C. Mastbergen, F.P. Lafeber. Univ. Med. Ctr.
Utrecht, Utrecht, NetherlandsPurpose: Biochemical markers (biomarkers) are proposed to reﬂect
certain metabolic pathways in health and disease. However, actual
molecular validity of biomarkers is often not deﬁnite. uCTX-II has been put
forward as a marker of collagen type II degradation being part of cartilage
degradation in osteoarthritis and is used as (surrogate) end point in
therapeutic trials. Here we present data that argue against this assumption
and warrant more cautious interpretation of uCTX-II levels.
Methods: uCTX-II, and the bone biomarkers uCTX-I, uNTX-I, sPINP and sOC
as well as the cartilagemarkers sCOMP, sCS846, and sPIIANPwere assessed
by ELISA in baseline samples of CHECK (Cohort Hip & Cohort Knee),
a cohort of 1002 individuals with early complaints of pain and/or stiffness
in knee and/or hip. Associations between biomarkers and between
biomarkers and demographics were investigated through multiple linear
regression analysis.
Results: uCTX-II was more strongly associated with bone markers than
with the cartilage markers, while the cartilage markers did not show such
strong associations with the bone markers. Moreover, both uCTX-II and
bone markers but not the other cartilage markers showed an abrupt
menopausal shift in woman at the age of 50-55 years, also when adjusted
for age and BMI.
Conclusions: The increased bone marker levels in postmenopausal
women are in accordance with the well-known increase in bone turnover
after menopause. The many similarities between uCTX-II and bone
markers could be attributable to a link between cartilage and bone
metabolism through metabolic and biomechanical mechanisms. However,
other cartilage markers were hardly associated with uCTX-II and did not
show such evident associations with bone markers. These data suggest
that uCTX-II has unique relations with bone markers as compared to other
cartilage markers and reﬂects bone rather than cartilage metabolism.
Accordingly, other authors have suggested osteoclastic resorption of
calciﬁed cartilage as the major origin of uCTX-II. More thorough molecular
validation of uCTX-II is required to better deﬁne its origin. Until then,
uCTX-II levels should be interpreted cautiously.
This study was funded by CHECK (Cohort Hip & Cohort Knee), an initiative
of the Dutch Arthritis Association.
145
THE ABILITY OF BIOCHEMICAL MARKERS TO REFLECT BURDEN AND
PROGRESSION IN (VERY) EARLY KNEE AND HIP OSTEOARTHRITIS:
DATA FROM CHECK
W.E. van Spil, N.W. Jansen, S.C. Mastbergen, J.W. Bijlsma, P.M. Welsing,
F.P. Lafeber. Univ. Med. Ctr. Utrecht, Utrecht, NETHERLANDS
Purpose: To investigate the ability of (combinations of) biochemical
markers (biomarkers) to reﬂect osteoarthritis (OA) burden and 5-year
progression in (very) early knee and hip OA. On the basis of systematic
review data it was hypothesized that biomarkers of cartilage and synovial
metabolism would appear superior to markers of bone metabolism.
Methods: Eleven biomarkers (Cartilage: uCTX-II, sCOMP, sPIIANP, sCS846.
Bone: uCTX-I, uNTX-I, sOC, sPINP. Bone/cartilage: sC1,2C. Synovial tissue:
sHA, sPIIINP) were assessed by ELISA or RIA in baseline samples from
CHECK (Cohort Hip & Cohort Knee), a prospective cohort of 1002 indi-
viduals with symptoms of (very) early knee and/or hip OA.
Knee and hip radiographs were obtained at baseline and after 2 and 5
years. OA burdenwas expressed as the summed Kellgren & Lawrence (K&L)
score for knees and hips at baseline. OA progression was expressed as the
area under the curve (AUC) of summed K&L scores.
Associations were investigated through multiple linear regression.
Biomarkers were used individually as well as in combinations of stan-
dardized scores (Z-scores). sCOMP was used in combination with cartilage
as well as synovial biomarkers.
Results: Data were complete for approximately 800 participants at base-
line and 725 participants at all time points. Baseline summed K&L grades 0,
1, 2, 3, and 4 were present in 33.9, 26.8, 24.0, 9.6, and 5.7% of participants,
respectively (maximum K&L grade¼1 for individual joints). AUC of sum-
med K&L grades between baseline and 5 years were 0, 1.5-3.0, 3.0-5.5, and
5.5-17.5 for 39.0, 18.3, 22.5, and 20.1% of participants, respectively.
At baseline, uCTX-II, sCOMP, sPIIANP, sHA, and sPIIINP showed statistically
signiﬁcant associations with the summed K&L score (maximum stan-
dardized betas 0.183, P¼0.000 and 0.161, P¼0.000 for sHA and uCTX-II,
able 1
igniﬁcantly different concentrations of cytokines, chemokines and growth factors
healthy and osteoarthritic synovial ﬂuid (average  sd; pg/ml). #p<0.001 and
p<0.05
Healthy
(average 
sd; pg/ml)
OA (average
 sd; pg/ml)
P-value
Eotaxin 22.4  21.4 8.0  18.8 *0.02
G-CSF 90.1  95.4 22.4  15.0 *0.03
IL-6 57.0  112.2 186.1  224.1 #0.001
IP-10 521.5  561.2 1073.6  999.0 #0.001
MDC 55.6  24.4 210.1  87.4 #0.001
MIP-1a 4.5  1.2 16.5  28.2 *0.05
MIP-1ß 12.7  10.6 35.0  44.7 *0.04
PDGF-AA 1.5  3.0 122.6  89.3 #0.001
RANTES 31.7  48.3 762.9  871.9 #0.001
sCD40L 1.0  2.3 29.2  42.3 *0.005
Leptin 837.3  1115 3008.1  3770 *0.01
IL-13 nd 18.1  39.5 *0.01
Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S79respectively), that persisted for sHA and uCTX-II after adjustment for age,
gender and BMI (stand betas 0.113, P¼0.003 and 0.129, P¼0.000, respec-
tively). Only cartilage marker combinations showed stronger associations
with baseline summed K&L grades than individual biomarkers (stand beta
0.150, P¼0.000 for uCTX-II+sCOMP+PIIANP+CS846 combination, after
adjustment).
Associations with AUC of the summed K&L score were statistically signif-
icant for uCTX-II, sCOMP, sPIIANP, and sCS846 (stand betas 0.089-0.133,
P<0.018) and persisted after adjustment for age, gender, BMI, and baseline
summed K&L score for sCOMP only (stand beta 0.105, P¼0.005). Stronger
associations were observed for cartilage and synovial combinations (stand
beta 0.128, P¼0.001 for uCTXII+sCOMP+sPIIANP+sCS846, and stand beta
0.110, P¼0.003 for sCOMP+sPIIINP).
Conclusions: Associations with burden and progression of (very) early
knee and hip OAwere observed for cartilage and synovial biomarkers. The
low grade of the associations may be due to limitations of biomarkers as
well as radiography in reﬂecting disease in OA, especially in early-stage
disease. Associations may be stronger at 10-year follow-up and/or when
using more sensitive measures of individual radiographic OA features (e.g.
osteophytes, joint space narrowing, etc). Nevertheless, together with
literature data these results indicate that the search for biomarkers for
(very) early OA should be primarily aimed at (combinations of) cartilage
and synovial metabolism.
This study was funded by CHECK (Cohort Hip & Cohort Knee), an initiative
of the Dutch Arthritis Association.
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OSTEOARTHRITIS BIOMARKERS IN HUMAN SERUM BY CHEMICAL
DEPLETION COUPLED TO TWO DIMENSIONAL DIFFERENCE IN GEL
ELECTROPHORESIS
C. Fernández-Costa 1, V. Calamia 1, J. Capelo 2, C. Ruiz-Romero 1,
F.J. Blanco 1. 1 INIBIC-CHUAC. Proteomic Group. ProteoRed/ISCIII.
Rheumatology Div., A Coruña, SPAIN; 2BIOSCOPE Group, Physical Chemistry
Dept., Sci. Facultaty, Univ. of Vigo at Ourense Campus, Ourense, SPAIN
Purpose: The aim of this study is to search for osteoarthritis (OA)
biomarkers in human serum using a novel chemical sequential depletion
method combined with two dimensional difference in-gel electrophoresis
(2D-DIGE) analyses.
Methods: The serum samples were obtained from 20 OA pacientes and 20
non-symptomatic controls. Samples were grouped into four pools of 10
samples each. The pools were subjected to a chemical sequential depletion
protocol involving two precipitation steps, ﬁrst with DTT and then with
ACN, to reduce the high dynamic range of the proteins. Then, the proteo-
mics comparison between OA and control sera was performed across four
DIGE gels. Samples from control and OA pools were labeled with Cy3 or
Cy5 dyes, mixed by pairs and co-resolved by two-dimensional gel elec-
trophoresis using a pool of all samples labeled with Cy2 as internal stan-
dard. The gels were imaged using a DIGE Imager scanner, and quantitative
image analysis was performed using Same Spots software. For protein
identiﬁcation, gel spots were digested by in-gel enzymatic digestion
accelerated with ultrasounds. Then, peptides were analyzed by mass
spectrometry (MALDI-TOF/TOF) and identiﬁed using Mascot with Swis-
sProt knowledgebase. Veriﬁcation of the alteration of SAA and HPT was
performed by immunoblotting.
Results: We report the combination of a novel chemical sequential
depletion method combined with 2D-DIGE for the search of OA
biomarkers. An average of 210 protein spots were detected and matched
on the gel images. The differential analysis resulted in 42 spots signiﬁ-
cantly and reproducibly altered between OA and control samples, 29
increased and 17 decreased. These 45 spots corresponded to 14 different
proteins, many of them related with lipid transport, immune response or
protein binding. We identiﬁed a spot corresponding to a serum amyloid A
protein form (SAA), which was decreased in OA sera when compared to
control. SAA is a major acute phase reactant implicated in the pathogenesis
of rheumatoid arthritis, however, the role of SAA in OA has been poorly
investigated. We also detected two spots corresponding to haptoglobin
precursor (HPT) that exhibited an opposite alteration in OA sera when
compared to control. HPT precursor is an N-linked glycoprotein known to
be cleaved into two chains, alpha and beta, which combine with freeplasma hemoglobin and contribute to the maintenance of cellular iron
homeostasis. Interestingly, HPT beta chain was increased in OA sera whilst
HPT alpha chain was decreased in OA sera when compared to control.
Western blot analyses were performed to conﬁrm these results. The
detection of modulated SAA and HPT protein forms in this work highlight
the usefulness of 2D gel-based approaches for characterizing disease-
speciﬁc patterns of protein modiﬁcations, which are impossible to obtain
from peptide/MS-based proteomic strategies.
Conclusions: We were able to identify 15 protein forms altered in the
disease, corresponding to 14 different proteins. The chemical sequential
depletion coupled to a DIGE-based quantitative proteomic analysis is
useful for protein biomarker discovery. We provide a list of potential OA
biomarker candidates that might be the subject of further validation
studies.
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A DESCRIPTIVE STUDY OF SYNOVIAL FLUID CHANGES IN CYTOKINE,
CHEMOKINE AND GROWTH FACTOR LEVELS BETWEEN
OSTEOARTHRITIS PATIENTS AND HEALTHY DONORS.
M. Beekhuizen 1, L. Gierman 2, L.B. Creemers 1, W.J. Dhert 1, T.W.
Huizinga 3, G.J. van Osch 4, A.-M. Zuurmond 2. 1UMC Utrecht, Utrecht,
NETHERLANDS; 2 TNO, Leiden, NETHERLANDS; 3 LUMC, Leiden,
NETHERLANDS; 4 Erasmus MC, Rotterdam, NETHERLANDS
Purpose: Many studies have shown differences between the healthy and
osteoarthritic (OA) joint environment. These studies are mainly based on
a limited set of cytokines, chemokines or growth factors. A comprehensive
proﬁle of these kind of mediators for OA patients could potentially
contribute to the search for new biomarkers or biomarker proﬁles. In the
current study, we analysed 49 soluble mediators in synovial ﬂuid (SF) in
order to examine differences in the healthy and OA joint environment
proﬁle.
Methods: SF was obtained from donors with macroscopically
healthy knee joints (post-mortem material; n¼16) and from OA
patients (total knee arthroplasy for OA; n¼18). All samples were
analyzed for a set of 49 different cytokines, chemokines and growth
factors using multiplex ELISA assays. A non-parametric Mann-Whit-
ney U test was used to determine signiﬁcant differences. Signiﬁcance
was set at p<0.001.
Results: The majority of the soluble mediators could be detected in both
healthy and OA SF. IL-6, IP-10, MDC, PDGF-AA and RANTES were signiﬁ-
cantly increased in OA compared to healthy SF (Table 1.; p<0.001). Leptin,
IL-13, MIP1-a, MIP1-b, sCD-40L were also increased in OA compared to
healthy SF, however less signiﬁcant (p<0.05). In contrast, eotaxin and G-
CSF were decreased in OA synovial ﬂuid (p<0.05). The levels of anabolic
factors such as FGF-2 and TGF-ß were not different between healthy and
OA SF samples.T
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